ArticleMicrobial cell factories2025
Multilocus identification and genetic enhancement of Trichoderma spp. for entomopathogenic activity against Spodoptera littoralis.
Article in Microbial cell factories, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond multilocus barcoding: harnessing phylogenomics and genome mining for next-generation Trichoderma-based bioproducts.Applied microbiology and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Egyptian cotton leafworm (Spodoptera littoralis) is a highly destructive, pesticide-resistant pest affecting over 80 economically important crops across the Mediterranean and African regions. While chemical insecticides offer temporary relief, their long-term use poses environmental and health risks, and resistance development reduces their effectiveness. Biological control using entomopathogenic fungi, particularly Trichoderma spp., offers a sustainable alternative. Traditionally, it is used against plant pathogens, Trichoderma harzianum, T. viride, T. asperellum, and T. longibrachiatum have also shown insecticidal potential through the production of compounds like peptaibols, gliotoxins, and chitinases, and by inducing systemic resistance in plants. However, the entomopathogenic potential of native Trichoderma isolates in Egypt remains undiscovered, and field performance is often inconsistent. This study aims to identify and evaluate native Trichoderma strains against S. littoralis and enhance their biocontrol efficacy through interspecific protoplast fusion a promising parasexual technique for strain improvement.
resultsMultilocus sequence analysis targeting the tef1-α and rpb2 genes identified the isolates as T. harzianum, T. asperellum, and T. longibrachiatum. Phylogenetic analysis clustered the isolates into three well-distinctive clades corresponding to these species. Among the tested isolates, Tricho19 (T. longibrachiatum), Tricho5 (T. asperellum), and Tricho30 (T. harzianum) demonstrated the highest extracellular chitinase activity and larval mortality in oral bioassays against S. littoralis. Interspecific protoplast fusion led to the generation of fusants with significantly enhanced chitinase production and insecticidal activity relative to their parental strains. Greenhouse assays confirmed the superior performance of fusant Fus8, which exhibited the highest larval mortality and antifeedant activity, closely approaching the efficacy of a chemical insecticide.
conclusionInterspecific protoplast fusion significantly improved the entomopathogenic performance of Trichoderma strains against S. littoralis. The enhanced activity of fusant strains, particularly Fus8, highlights the potential of this cost-effective strategy to generate improved biocontrol agents. These findings contribute to the development of sustainable pest management alternatives that can reduce reliance on chemical pesticides in agriculture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.